You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
After closing its doors last September, Nabsys has resumed operations, refocusing on its core technology.
Access to the full genome map is expected to boost efforts to develop more resistant, higher-yield varieties of wheat.
Gene Company will distribute BioNano's Irys genome mapping system in China, except for Shanghai, with exclusive rights in Hong Kong and Macau.
A Mount Sinai-led team of researchers combined the technologies to generate de novo assemblies and get a better view of structural variations.
Researchers are turning to graph theory to design a better way to map the human reference genome.
Homozygous recessive mutations in the gene PRDM12 appear to contribute to congenital insensitivity to pain by interfering with sensory nerve development.
The researchers used multiple sequencing technologies, library preparations, assembly methods, and genome mapping tools toward creating a reference diploid genome.
The company was founded in 2002 with a whole-genome mapping technology and more recently moved into the microbial genetics space.
The genomic mapping firm will use the financing to further its commercialization work, R&D, and prepare an entry into the clinical space.
Nabsys CEO Steve Lombardi and CSO Tony Shuber spoke with GenomeWeb at last week's JP Morgan conference in San Francisco.
Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.
Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language.
Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.
In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.